Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Veloxis Pharmaceuticals submits NDA to US FDA to market Envarsus for kidney transplant recipients
Pharmabiz.com
Tuesday, December 31, 2013 - 11:36am
tags:
FDA, Veloxis, Envarsus, kidney translants
Pipeline Setback at Can-Fite BioPharma, Shares Down
Yahoo/Zacks.com
Tuesday, December 31, 2013 - 11:31am
tags:
Can-Fite BioPharma, CF101
China halts imports of Pfizer drug on paperwork glitch
Reuters
Tuesday, December 31, 2013 - 10:36am
tags:
China, Pfizer
Merck is cutting 150 in its Saphris sales team after selling the drug to Forest for $240M
Fierce Pharma
Tuesday, December 31, 2013 - 10:32am
tags:
Saphris, Merck, layoffs, drug reps, Forest Labs
Cellular Therapy: Representing The Paradigm Shift In Healthcare
Seeking Alpha
Tuesday, December 31, 2013 - 10:26am
tags:
NeoStem, stem cells, Baxter International, AMR-001
Stryker to buy Patient Safety Technologies for $120 mln
Yahoo/Reuters
Tuesday, December 31, 2013 - 10:19am
tags:
Patient Safety Technologies, M&A, Stryker, devices
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tuesday, December 31, 2013 - 10:17am
tags:
Bristol-Myers Squibb, Celgene, Gilead Sciences, Biogen Idec, AbbVie, Roche, JNJ, GSK, Amgen, Novo Nordisk, Pfizer, Novartis, Merck, Sanofi, AstraZeneca, Eli Lilly
Understanding Zerenex's Patent Protection And Latest Issuance
Seeking Alpha
Tuesday, December 31, 2013 - 10:13am
tags:
Zerenex, patents, Keryx
Jazz, Valeant Join Drug Makers' Q4 Merger Rush
Investors.com
Monday, December 30, 2013 - 7:26pm
tags:
Valeant Pharmaceuticals, Jazz Pharmaceuticals, M&A
A Hard Lesson from Sanofi
WSJ Online
Monday, December 30, 2013 - 5:48pm
tags:
Sanofi, Genzyme, Lemtrada, FDA, MS, multiple sclerosis
Karolinska's Axelar comes up short in Phase II with lung cancer drug
Fierce Biotech
Monday, December 30, 2013 - 5:45pm
tags:
Axelar, AXL1717, non-small cell lung cancer
Solana Surgical lands FDA clearance for orthopedic implant
Mass Device
Monday, December 30, 2013 - 5:43pm
tags:
devices, orthopedic implants, Solana Surgical, CrossCheck plating system
U.S. new drug approvals slip in 2013 vs prior year
Yahoo/Reuters
Monday, December 30, 2013 - 5:34pm
tags:
FDA, drug approvals
Actavis' Women Health Biz Update
Yahoo/Zacks.com
Monday, December 30, 2013 - 5:33pm
tags:
Actavis, contraceptives, Women's Health, contraceptive rings, contraceptive patch
OphthaliX’s dry eye drug fails endpoint in Phase III study
Pharmaceutical Business Review
Monday, December 30, 2013 - 12:10pm
tags:
OphthaliX, dry eye disease, CF101
What Does the ViroPharma Buyout Mean for BioMarin?
Motley Fool
Monday, December 30, 2013 - 12:06pm
tags:
ViroPharma, M&A, Biomarin, Shire
OncoSec Medical Poised for Exciting 2014
Wall St Cheat Sheet
Monday, December 30, 2013 - 11:39am
tags:
OncoSec Medical, melanoma, skin cancer, immunotherapy
Myriad Genetics: How Low Can It Go?
Barron's
Monday, December 30, 2013 - 11:37am
tags:
Myriad Genetics, breast cancer, diagnostics
The Billion-Dollar Biotech Club: Speculation Trumped Risk
TheStreet.com
Monday, December 30, 2013 - 11:35am
tags:
biotech
FDA starts review of Cubist Pharma antibiotic
Yahoo/AP
Monday, December 30, 2013 - 11:33am
tags:
FDA, antibiotics, Cubist Pharmaceuticals, tedizolid

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.